Tadalafil citrate was first developed as a cardiovascular compound, but its potential for treating ED was realized in the mid-1990s. Marketed as Cialis from 2003, it offered a long-acting alternative to sildenafil, with a half-life of 17.5 hours and up to 36 hours of therapeutic effect. This extended window made it ideal for once-daily dosing, later approved in 2008. Unlike older methods requiring planning or injections, tadalafil citrate supported a spontaneous, lifestyle-friendly approach to sexual health management.
Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Tadalafil 10 by Androlex, consult with your doctor or healthcare professional.
Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.
Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.
Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.